The Patent Finder

Dendreon Corporation

Also on record
Records under this name other than the patents Dendreon Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.

Back to Dendreon Corporation

PatentTitleStatus Expires Confidence
US 7,597,894Compositions and Methods Employing Alternative Reading Frame Polypeptides for the Treatment of Cancer and Infectious Disease
Formerly held
In force
 · High confidence
In forceHigh confidence
US 7,972,602Promiscuous HER-2/NEU CD4 T Cell Epitopes
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,153,120Methods for Inducing a Natural Killer (NK) Cell-Mediated Immune Response and for Increasing NK Cell Activity
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,361,479Promiscuous Pap CD4 T Cell Epitopes
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,261,091Humoral Immune Response Against Tumor Antigens After Treatment with a Cancer Antigen Specific Active Immunotherapy and Its Association with Improved Clinical Outcome
Formerly held
In force
 · High confidence
In forceHigh confidence
US 7,572,444Binding Proteins Specific for Human Matriptase
Formerly held
Term ended
Term ended Dec 16, 2025 · High confidence
Term endedTerm ended Dec 16, 2025High confidence
US RE43,298Peptides as NS3-SERINE Protease Inhibitors of Hepatitis C Virus
Term ended
Term ended Dec 22, 2024 · Low confidence
Term endedTerm ended Dec 22, 2024Low confidence
US 7,132,398Method of Treatment of Hemorrhagic Disease Using a Factor Viia/Tissue Factor Inhibitor
Formerly held
Term ended
Term ended Jan 29, 2024 · High confidence
Term endedTerm ended Jan 29, 2024High confidence
US 7,413,869Method for Determining Potency of Antigenic Presenting Cell Based Vaccines
Formerly held
Term ended
Term ended Nov 12, 2022 · High confidence
Term endedTerm ended Nov 12, 2022High confidence
US 6,962,795Neutrophil inhibitors
Formerly held
Term ended
Term ended Nov 8, 2022 · From the USPTO record
Term endedTerm ended Nov 8, 2022From the USPTO record
10 of 91 patents shown.
Pro members see all 91.
Pro members: see all 91 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited